Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Allergy Thera. (AGY)

Price 2.85p on 24-04-2024 at 16:30:04
Change 0.05p 1.79%
Buy 2.90p
Sell 2.80p
Buy / Sell AGY Shares
Last Trade: Sell 30,000.00 at 2.80p
Day's Volume: 919,062
Last Close: 2.85p
Open: 2.80p
ISIN: GB00B02LCQ05
Day's Range 2.80p - 2.85p
52wk Range: 0.85p - 6.25p
Market Capitalisation: £136m
VWAP: 2.875057p
Shares in Issue: 4,766m

Recent Trades History Allergy Thera. (AGY)

Buy/Sell Volume Trade Prc Trade Type Trade Time
Sell* 30,000 2.80p Ordinary
15:32:18 - 24-Apr-24
Sell* 683 2.80p SI Trade
15:19:14 - 24-Apr-24
Buy* 11,724 2.90p Ordinary
14:57:33 - 24-Apr-24
Buy* 13 2.8625p Ordinary
14:22:20 - 24-Apr-24
Buy* 36,142 2.8625p Ordinary
13:32:05 - 24-Apr-24
Unknown* 250,000 2.90p Ordinary
12:05:43 - 24-Apr-24
Buy* 100,000 2.90p Ordinary
12:05:40 - 24-Apr-24
Buy* 210,000 2.85p Ordinary
12:05:30 - 24-Apr-24
Buy* 30,000 2.90p Ordinary
11:38:13 - 24-Apr-24
Buy* 100,000 2.85p Ordinary
11:38:04 - 24-Apr-24

Share Price History for Allergy Thera.

Time period:
to
Date Open High Low Close Volume

Share News for Allergy Thera.

EARNINGS AND TRADING: Solid State ups outlook; Quartix trading in line

27th Mar 2024 16:13

(Alliance News) - The following is a round-up of earnings and trading updates by London-listed companies, issued on Wednesday and not separately reported by Alliance News: Read More

AIM WINNERS & LOSERS: Norman Broadbent profit swing on rising revenue

27th Mar 2024 11:02

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Wednesday. Read More

Allergy Therapeutics starts dosing patients in peanut allergy trial

12th Mar 2024 14:06

(Alliance News) - Allergy Therapeutics PLC on Tuesday said it has commenced subcutaneous dosing of peanut allergic patients in its phase 1/2a Protect trial. Read More

UK shareholder meetings calendar - next 7 days

1st Mar 2024 15:49

Read More

Allergy Therapeutics forecasts revenue drop but trials going well

14th Feb 2024 10:22

(Alliance News) - Allergy Therapeutics PLC on Wednesday said revenue decreased in its latest half year, and expects to require further funding soon. Read More

FTSE 100 Latest
Value8,040.38
Change-4.43

Login to your account

Forgot Password?

Not Registered